A Single Arm, Prospective, Open Label, Multi Center, Phase Ib Study to Evaluate the Safety, Tolerability and Initial Efficacy of a Single Intra-tumoral Injection of IntraGel's Polymer-based Cisplatin-loaded Gel (TumoCure) in Subjects With Progressive or Radio-resistant Primary Head and Neck Tumor

NCT05200650 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

IntraGel Therapeutics